Miljöpåverkan
Dekvalinium
Miljörisk:
Risk för miljöpåverkan av dekvalinium kan inte uteslutas då ekotoxikologiska data saknas.
Nedbrytning:
Det kan inte uteslutas att dekvalinium är persistent, då data saknas.
Bioackumulering:
Dekvalinium har låg potential att bioackumuleras.
Läs mer
Detaljerad miljöinformation
Environmental Risk Classification
Predicted Environmental Concentration (PEC)
PEC is calculated according to the following formula based on the following formula: PEC (μg/L) = (A*109*(100-R))/(365*P*V*D*100) = 1.37*10-6*A(100-R)
PEC = 0,000352 μg/L
Where:
A = 2.5699 kg (total sold amount Dequalinium Chloride in Sweden year 2021, data from IQVIA).
R = 0 % removal rate.
P = number of inhabitants in Sweden = 10 *106
V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (Ref. I)
D = factor for dilution of wastewater by surface water flow = 10 (ECHA default) (Ref. I)
According to the European Medicines Agency guideline on environmental risk assessment of medicinal products (EMA/CHMP/SWP/4447/00), use of dequalinium chloride is unlikely to represent a risk for the environment, because the predicted environmental concentration (PEC) at the time of registration was below the action limit 0.01 µg/L.
Predicted No Effect Concentration (PNEC)
Ecotoxicological studies
No ecotoxicological data are available.
Environmental risk classification (PEC/PNEC ratio)
As no ecotoxicological data are available, the PEC/PNEC ratio cannot be calculated. This justifies the phrase "Risk of environmental impact of dequalinium chloride cannot be excluded, since no ecotoxicity data are available".
Degradation
No degradation data are available.
Bioaccumulation
Partitioning coefficient:
Log Kow < -2.1 at 20oC (Ref. II)
Since log Kow < 4, dequalinium chloride has low potential for bioaccumulation.
References
I. ECHA 2008. European Chemicals Agency. 2008 Guidance on information requirements and chemical safety assessment. http://guidance.echa.europa.eu/docs/guidance_document/information_requirements_en.htm
II. Environmental Risk Assessment for Fluomizin. Prepared for Medinova AG, 2011 by Monika Chabicovsky at Granzer.